122 related articles for article (PubMed ID: 2906191)
21. The effect of anthralin (dithranol) on mitochondria.
Morlière P; Dubertret L; Sa e Melo T; Salet C; Fosse M; Santus R
Br J Dermatol; 1985 May; 112(5):509-15. PubMed ID: 4005152
[TBL] [Abstract][Full Text] [Related]
22. Comparison of dithranol and butantrone in short contact therapy of psoriasis.
Göransson A
Acta Derm Venereol; 1987; 67(2):149-53. PubMed ID: 2438880
[TBL] [Abstract][Full Text] [Related]
23. The influence of treatment of the paralesional skin with dithranol on healing in psoriasis.
Stankler L; Dave VK
Br J Dermatol; 1975 Jan; 92(1):57-61. PubMed ID: 1098687
[TBL] [Abstract][Full Text] [Related]
24. Effect of dithranol treatment on arachidonic acid and its lipoxygenase products in psoriasis.
Barr RM; Wong E; Cunningham FM; Mallet AI; Greaves MW
Arch Dermatol Res; 1989; 280(8):474-6. PubMed ID: 2537608
[TBL] [Abstract][Full Text] [Related]
25. The effects of topical corticosteroids and a coal tar preparation on dithranol-induced irritation in patients with psoriasis.
Swinkels OQ; Kucharekova M; Prins M; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):12-7. PubMed ID: 12566824
[TBL] [Abstract][Full Text] [Related]
26. Effects of Mahonia aquifolium ointment on the expression of adhesion, proliferation, and activation markers in the skin of patients with psoriasis.
Augustin M; Andrees U; Grimme H; Schöpf E; Simon J
Forsch Komplementarmed; 1999 Apr; 6 Suppl 2():19-21. PubMed ID: 10352377
[TBL] [Abstract][Full Text] [Related]
27. Epidermal calmodulin levels in psoriasis before & after therapy.
Kaur I; Kaur S; Vaishnavi C; Ganguly NK; Garg J; Kohli M
Indian J Med Res; 1991 Apr; 94():130-3. PubMed ID: 1879887
[TBL] [Abstract][Full Text] [Related]
28. The effects of topical treatment with steroids or dithranol on epidermal T lymphocytes and dendritic cells in psoriasis.
Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H
Scand J Immunol; 1985 Nov; 22(5):471-7. PubMed ID: 2934800
[TBL] [Abstract][Full Text] [Related]
29. [Skin reaction to dithranol and its modification by the addition of tar (LCD)].
Bratzke B; Albrecht G; Orfanos CE
Hautarzt; 1987 Jun; 38(6):356-60. PubMed ID: 2958429
[TBL] [Abstract][Full Text] [Related]
30. [Experiences with high-dosage short-term dithranol therapy of psoriasis].
Göring HD; Voss M
Hautarzt; 1984 Mar; 35(3):148-51. PubMed ID: 6715170
[TBL] [Abstract][Full Text] [Related]
31. Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
Remitz A
Acta Derm Venereol; 1989; 69(4):351-4. PubMed ID: 2568062
[TBL] [Abstract][Full Text] [Related]
32. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
Mustakallio KK; Brandt H
Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
[TBL] [Abstract][Full Text] [Related]
33. Low strength anthralin in psoriasis.
Montes LF; Wilborn WH; Brody I
J Cutan Pathol; 1979 Dec; 6(6):445-56. PubMed ID: 42654
[TBL] [Abstract][Full Text] [Related]
34. The systemic effect of dithranol treatment in psoriasis.
Goodfield MJ; Hull SM; Cunliffe WJ
Acta Derm Venereol; 1994 Jul; 74(4):295-7. PubMed ID: 7976091
[TBL] [Abstract][Full Text] [Related]
35. An immunohistochemical assessment of the response of the psoriatic lesion to single and repeated applications of high-dose dithranol cream.
Swinkels OQ; Prins M; Gerritsen MJ; van Vlijmen-Willems IM; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2002; 15(6):393-400. PubMed ID: 12476013
[TBL] [Abstract][Full Text] [Related]
36. Electron microscopy of psoriatic skin before and after psoralen/ultraviolet A treatment.
Mete UO; Denli YG; Ozbilgin MK; Tap O; Acar MA; Kaya M; Memisoglu HR
Cutis; 1996 Jul; 58(1):83-6. PubMed ID: 8823556
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy of narrow-band UVB (311 nm) combined with dithranol in psoriasis. An open pilot study.
Carrozza P; Häusermann P; Nestle FO; Burg G; Böni R
Dermatology; 2000; 200(1):35-9. PubMed ID: 10681611
[TBL] [Abstract][Full Text] [Related]
38. Effects of dithranol on neutrophil superoxide generation in patients with psoriasis.
Kavanagh GM; Burton JL; Donnell VO
Br J Dermatol; 1996 Feb; 134(2):234-7. PubMed ID: 8746335
[TBL] [Abstract][Full Text] [Related]
39. Experimental contribution to the dithranol-brown problem.
Wiegrebe W; Plumier E; Mayer KK; Runne U; Schultz-Amling W; Rosmarinowski J; Safar GJ; Kubka KD
Arch Dermatol Res; 1985; 277(2):153-5. PubMed ID: 3985673
[No Abstract] [Full Text] [Related]
40. Irritant potential of dithranol.
Haustein UF; Lohrisch I
Dermatologica; 1986; 173(6):288-93. PubMed ID: 3817240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
